IP Library Assignment 048645/0673
Patent Assignment
Reel/Frame 048645/0673

Assignment of Assignor's Interest

Recorded: 2019-03-20 Pages: 14
Assignor
ARGOS THERAPEUTICS, INC.
Executed: 2019-01-22
Assignee
COIMMUNE, INC.
4233 TECHNOLOGY DR., DURHAM, NORTH CAROLINA, 27704
Covered Properties (82)
Strain-Independent Amplification of Pathogens and Vaccines Thereto
Application: 60/522,310 →
Strain-independent amplification of pathogens and vaccines thereto
Application: 60/665,130 →
Mature Dendritic Cell Compositions and Methods of Culturing Same
Application: 11/664,899 →
Publication: US 2008/0145931
Mature Dendritic Cell Compositions and Methods for Culturing Same
Application: 15/385,559 →
Publication: US 2017/0096640
Mature Dendritic Cell Compositions and Methods of Culturing Same
Application: 12/226,092 →
Publication: US 2012/0269832
Apparatus for delivery of a liquid medicament to a syringe
Application: 60/726,396 →
Dendritic cell compositions and methods
Application: 60/669,468 →
Dendritic Cell Compositions and Methods
Application: 13/929,889 →
Publication: US 2013/0280805
Dendritic Cell Compositions and Methods
Application: 14/307,991 →
Publication: US 2015/0132844
Dendritic Cell Compositions and Methods
Application: 14/879,336 →
Publication: US 2016/0102291
System and method for processing samples in a closed container
Application: 60/760,087 →
CD4+CD25- T cells and Tr1-like regulatory T cells
Application: 60/419,177 →
Use of soluble CD83 for tolerization to a therapeutic composition
Application: 60/838,812 →
Use of CD83 in combination therapies
Application: 60/927,377 →
Use of CD83 in combination therapies
Application: 12/308,306 →
Publication: US 2014/0010821
Use of CD83 in Combination Therapies
Application: 14/872,356 →
Publication: US 2016/0008440
Use of CD83 in Combination Therapies
Application: 15/155,287 →
Publication: US 2016/0324926
Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides
Application: 60/962,510 →
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
Application: 61/067,459 →
Tscm Cells and Methods for Use
Application: 61/943,278 →
Tscm Cells and Methods for Use
Application: 61/947,355 →
Tscm CELLS AND METHODS FOR USE
Application: 15/120,236 →
Publication: US 2017/0065690
Bispecific Antibodies that Modulate TLR-4 Signaling and Uses Thereof
Application: 62/418,713 →
Methods and Uses for Dendritic Cell Therapy
Application: 62/582,853 →
Methods of Making Natural Killer Cells and Uses Thereof
Application: 62/677,019 →
Centrifuge Vessels Suitable for Live Cell Processing and Associated Systems and Methods
Application: 61/592,759 →
Automated Processing Systems, Apparatus, Methods and Related Devices
Application: 62/531,918 →
In Situ Maturation of Dendritic Cells
Patent: 7,785,583 →
Application: 10/536,211 →
Publication: US 2006/0121003
Cryoconserved Mature Dendritic Cells
Patent: 8,574,901 →
Application: 13/479,612 →
Publication: US 2012/0301959
Method for Producing Ready to Use, Antigen-Loaded or Unloaded, Cryoconserved Mature Dendritic Cells
Patent: 8,236,562 →
Application: 10/362,715 →
Publication: US 2004/0253574
Strain-Independent Amplification of Pathogens and Vaccines Thereto
Patent: 9,085,807 →
Application: 11/662,828 →
Publication: US 2008/0311155
Strain-Independent Amplification of Pathogens and Vaccines Thereto
Patent: 9,879,053 →
Application: 14/659,487 →
Publication: US 2015/0252083
Mature dendritic cell compositions and methods for culturing same
Patent: 8,513,008 →
Application: 11/400,774 →
Publication: US 2007/0082400
Mature Dendritic Cell Compositions and Methods for Culturing Same
Patent: 9,523,077 →
Application: 13/941,627 →
Publication: US 2014/0017788
Mature Dendritic Cell Compositions and Methods for Culturing Same
Application: 15/383,574 →
Publication: US 2017/0096639
Mature Dendritic Cell Compositions and Methods for Culturing Same
Patent: 8,822,223 →
Application: 11/246,387 →
Publication: US 2006/0078994
Mature Dendritic Cell Compositions and Methods for Culturing Same
Patent: 9,556,455 →
Application: 14/473,868 →
Publication: US 2015/0072431
Use of Soluble Forms of CD83 and Nucleic Acids Encoding Them for the Treatment or Prevention of Diseases
Patent: 7,893,200 →
Application: 10/535,522 →
Publication: US 2007/0167607
Use of Soluble Forms of CD83 and Nucleic Acids Encoding Them for the Treatment or Prevention of Diseases
Patent: 8,759,505 →
Application: 13/011,380 →
Publication: US 2012/0015890
Use of Soluble Forms of CD83 and Nucleic Acids Encoding Them for the Treatment or Prevention of Diseases
Patent: 9,732,140 →
Application: 14/306,712 →
Publication: US 2015/0065684
Nucleic Acid or Recombination Expression Vector Encoding Soluble Forms of CD83, Host Cells Transformed/Transfected Therewith and Pharmaceutical Compositions Containing Same
Patent: 9,102,726 →
Application: 10/382,397 →
Publication: US 2004/0110673
Soluble CD83 Proteins and Use Thereof for the Treatment or Prevention of a Disease or Medical Condition Caused by Dysfunction or Undesired Function of a Cellular Immune Repsonse Involving T Cells
Patent: 7,169,898 →
Application: 10/309,611 →
Publication: US 2004/0116338
Soluble CD83 Proteins and Use Thereof for the Treatment and Prevention of a Disease or Medical Condition Caused by Dysfunction or Undesired Function of a Cellular Immune Response Involving T Cells
Patent: 8,124,099 →
Application: 11/699,918 →
Publication: US 2007/0212370
Devices, Systems and Related Methods Suitable for Delivery of a Liquid Medicament Stored at Cryogenic Temperatures
Patent: 8,672,879 →
Application: 12/066,865 →
Publication: US 2009/0204071
Dendritic Cell Compositions and Methods
Patent: 8,153,425 →
Application: 11/918,076 →
Publication: US 2009/0053251
Dendritic Cell Compositions and Methods
Patent: 46,152 →
Application: 14/450,092 →
Dendritic Cell Compositions and Methods
Patent: 8,501,470 →
Application: 13/351,510 →
Publication: US 2012/0114680
Systems and Methods for Processing Samples in a Closed Container, and Related Devices
Patent: 8,030,080 →
Application: 12/159,748 →
Publication: US 2009/0298129
Methods for Processing Samples in a Closed Container
Patent: 8,211,701 →
Application: 13/235,922 →
Publication: US 2012/0021422
Apparatus for Transfer of Liquid for Processing Samples
Patent: 8,431,404 →
Application: 13/490,863 →
Publication: US 2012/0270310
Apparatus for Measuring Volume of a Fluid
Patent: 9,040,303 →
Application: 13/845,725 →
Publication: US 2013/0217105
Processing Containers
Patent: 9,409,178 →
Application: 14/692,131 →
Publication: US 2015/0224506
Processing Containers
Patent: 9,527,074 →
Application: 15/216,128 →
Publication: US 2016/0326573
Methods of Processing Samples
Patent: 9,638,707 →
Application: 15/357,347 →
Publication: US 2017/0067925
CD4+CD25- T Cells and TR1-Like Regulatory T Cells
Patent: 8,222,033 →
Application: 10/618,134 →
Publication: US 2004/0147021
CD4+CD25- T Cells and TR1-Like Regulatory T Cells
Patent: 8,076,134 →
Application: 11/765,720 →
Publication: US 2007/0258959
CD4+CD25- T Cells and TR1-Like Regulatory T Cells
Patent: 8,603,815 →
Application: 13/289,409 →
Publication: US 2012/0114597
Primers and Probes for the Amplification and Detection of Hiv Gag,Rev and Nef Polynucleotides
Patent: 8,221,981 →
Application: 12/452,580 →
Publication: US 2010/0136631
Primers and Probes for the Amplification and Detection of HIV GAG, REV and NEF Polynucleotides
Patent: 9,970,068 →
Application: 13/479,335 →
Publication: US 2012/0231509
Transient Expression of Immunomodulatory Polypeptides for the Prevention and Treatment of Autoimmune Disease, Allergy and Transplant Rejection
Patent: 8,513,208 →
Application: 12/735,932 →
Publication: US 2011/0081327
Centrifuge Vessels with a Center Mound and an Internal Elongate Tube Suitable for Live Cell Processing and Associated Systems and Methods
Application: 14/372,944 →
Publication: US 2014/0364296
Humanized Antibodies Against Human Interferon-Alpha
Patent: 8,658,771 →
Application: 13/719,536 →
Publication: US 2013/0101602
Humanized Antibodies Against Human Interferon-Alpha
Patent: 8,361,463 →
Application: 13/363,609 →
Publication: US 2012/0195888
Humanized Antibodies Against Human Interferon-Alpha
Patent: 8,163,885 →
Application: 12/597,357 →
Publication: US 2011/0213125
Method for in Vitro Proliferation of Dendritic Cell Precursors and Their Use to Produce Immunogens
Patent: 7,923,247 →
Application: 12/218,899 →
Publication: US 2009/0029469
Method and Compositions for Obtaining Mature Dendritic Cells
Patent: 7,659,119 →
Application: 08/600,483 →
Publication: US 2003/0096314
Method and Compositions for Obtaining Mature Dendritic Cells
Patent: 7,198,948 →
Application: 10/047,072 →
Publication: US 2002/0160430
In Situ Maturation of Dendritic Cells
Strain Independent Amplification of Pathogens and Vaccines Thereto
Mature Dendritic Cell Compositions and Methods for Culturing Same
Mature Dendritic Cell Compositions and Methods
Devices, Systems and Related Methods Suitable for Delivery of a Liquid Medicament Stored at Cryogenic Temperatures
Dendritic Cell Compositions and Methods
Systems and Methods for Processing Samples in a Closed Container, and Related Devices
Balloon for Stent Member
Improved Primers and Probes for the Amplification and Detection of Hiv Gag, Rev and Nef Polynucleotides
Transient Expression of Immunomodulatory Polypeptides for the Prevention and Treatment of Autoimmune Disease, Allergy and Transplant Rejection
Tscm Cells and Methods for Use
Bispecific Antibodies That Modulate Tlr-4 Signaling and Uses Thereof
Methods and Uses for Dendritic Cell Therapy
Centrifuge Vessels Suitable for Live Cell Processing and Associated Systems and Methods
Automated Processing Systems, Apparatus, Methods and Related Devices
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 1, 2003
From: SCHULER, GEROLD; SCHULER-THURNER, BEATRICE
To: MERIX BIOSCIENCE, INC.
Reel/Frame 014168/0197 →
Assignment of Assignor's Interest Oct 21, 2004
From: NICOLETTE, CHARLES; TCHEREPANOVA, IRINA; HARRIS, JASON
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 015273/0477 →
Assignment of Assignor's Interest May 5, 2005
From: NICOLETTE, CHARLES; TCHEREPANOVA, IRINA; HARRIS, JASON
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 016519/0176 →
Assignment of Assignor's Interest May 20, 2005
From: CALEY, REBECCA; MONESMITH, TAMARA; TCHEREPANOVA, IRINA; DINTERMAN, LOIS
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 016585/0082 →
Assignment of Assignor's Interest Jun 5, 2006
From: PEELE, TIMOTHY D.; HUNTER, WILLIAM S.; HARRIS, SIMON P.; GRANT, RICHARD A.
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 017962/0779 →
Assignment of Assignor's Interest Apr 20, 2007
From: NICOLETTE, CHARLES; TCHEREPANOVA, IRINA; HARRIS, JASON; HEALEY, DONALD
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 019196/0502 →
Change of Name May 24, 2007
From: MERIX BIOSCIENCE, INC.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 019340/0373 →
Assignment of Assignor's Interest May 29, 2007
From: NICOLETTE, CHARLES
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 019354/0594 →
Assignment of Assignor's Interest Jun 5, 2007
From: NICOLETTE, CHARLES; BRAND, STEPHEN; ZHONG, ZHEN; WANG, HAO
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 019386/0313 →
Assignment of Assignor's Interest Sep 28, 2007
From: HEALEY, DONALD; TCHEREPANOVA, IRINA; ADAMS, MELISSA; HINOHARA, ATSUSHI
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 019956/0206 →
Assignment of Assignor's Interest Mar 6, 2008
From: TCHEREPANOVA, IRINA; STARR, AIJING; LACKFORD, BRAD
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 020608/0372 →
Assignment of Assignor's Interest Nov 11, 2008
From: POGUE-CALEY, REBECCA; MONESMITH, TAMARA; TCHEREPANOVA, IRINA; DINTERMAN, LOIS
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 021818/0818 →
Assignment of Assignor's Interest Feb 25, 2009
From: FATHMAN, C. GARRISON, MD.; CREUSOT, REMI
To: BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE
Reel/Frame 022311/0519 →
Assignment of Assignor's Interest Feb 26, 2009
From: NICOLETTE, CHARLES
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 022316/0808 →
Change of Name May 28, 2010
From: MERIX BIOSCIENCE, INC.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 024460/0982 →
Change of Name Jun 14, 2010
From: KAISHA, KIRIN BEER KABUSHI
To: KIRIN HOLDINGS KABUSHIKI KAISHA
Reel/Frame 024534/0049 →
Assignment of Assignor's Interest Jun 14, 2010
From: KIRIN HOLDINGS KABUSHIKI KAISHA
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 024534/0045 →
Assignment of Assignor's Interest Jul 28, 2010
From: KYOWA HAKKO KIRIN CO., LTD.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 024753/0219 →
Assignment of Assignor's Interest Jul 26, 2011
From: HEALEY, DONALD, PH.D; TCHEREPANOVA, IRINA; ADAMS, MELISSA; HINOHARA, ATSUSHI
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 026650/0228 →
Change of Name Jul 26, 2011
From: KIRIN BEER KABUSHIKI KAISHA
To: KIRIN HOLDINGS KABUSHIKI KAISHA
Reel/Frame 026653/0407 →
Assignment of Assignor's Interest Jul 26, 2011
From: KYOWA HAKKO KIRIN CO., LTD.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 026650/0650 →
Assignment of Assignor's Interest Jul 26, 2011
From: KIRIN HOLDINGS KABUSHIKI KAISHA
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 026650/0603 →
Assignment of Assignor's Interest Jul 27, 2011
From: NICOLETTE, CHARLES, PHD
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 026658/0835 →
Assignment of Assignor's Interest Aug 24, 2011
From: KIRIN HOLDINGS KABUSHIKI KAISHA (KIRIN HOLDINGS CO., LTD.)
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 026799/0572 →
Assignment of Assignor's Interest Sep 19, 2011
From: KYOWA HAKKO KIRIN CO., LTD.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 026925/0124 →